Elamipretide (SS31) Peptide
Unlock the potential of Elamipretide (SS-31) with our comprehensive short course. Delve into the intricacies of SS-31, from its clinical pharmacology and safety results to its therapeutic use cases and dosing protocols.
Introduction from Jessica Alana
CPD Eligibility
Primary Mitochondrial Myopathy - Mechanism of Disease
The Role of Mitochondria and the Phospholipid Cardiolipin in Health and Disease
Barth Syndrome Mechanism of Disease
RECLAIM-2 Elamipretide Safety & Efficacy Results Presentation
Mitochondria & Disease
Overview of Elamipretide (SS-31)
Clinical Pharmacology of Elamipretide
Indications and Therapeutic Use Cases
Dosing Protocols
Adverse Effects
Australian Practitioners
Research
Patient Education Sheet